Health care utilization in chronic obstructive pulmonary disease - A case-control study in a health maintenance organization

被引:188
作者
Mapel, DW
Hurley, JS
Frost, FJ
Petersen, HV
Picchi, MA
Coultas, DB
机构
[1] Univ New Mexico, Hlth Sci Ctr, Epidemiol & Canc Control Program, Albuquerque, NM 87131 USA
[2] Lovelace Resp Res Inst, SW Ctr Managed Care Res, Albuquerque, NM USA
关键词
D O I
10.1001/archinte.160.17.2653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Information about health care utilization and costs among patients with chronic obstructive pulmonary disease (COPD) is needed to improve care and for appropriate allocation of resources for patients with COPD (COPD patients or cases) in managed care organizations. Methods: Analysis of all inpatient, outpatient, and pharmacy utilization of 1522 COPD patients continuously enrolled during 1997 in a 172484-member health maintenance organization. Each COPD case was matched with 3 controls (n=4566) by age (+/-5 years) and sex. Information on tobacco use acid comorbidities was obtained by chart review of 200 patients from each group. Results: Patients with COPD were 2.3 times more likely to be admitted to the hospital at least once during the year, and those admitted had longer average lengths of stay (4.7 vs 3.9 days; P<.001). Mean costs per case and control were $5093 vs $2026 for inpatient services, $5042 vs $3050 for outpatient services, and $1545 vs $739 for outpatient pharmacy services, respectively (P<.001 for all differences). Patients with COPD had a longer smoking history (49.5 vs 34.9 pack-years; P=.002) acid a higher prevalence of smoking-related comorbid conditions and were more likely to use cigarettes during the study period (46.0% vs 13.5%; P<.001). Conclusions: Health care utilization among COPD patients is approximately twice that of age- and sex-matched controls, with much of the difference attributable to smoking-related diseases. In this health maintenance organization, inpatient costs were similar to and outpatient costs were much higher than national averages for COPD patients covered by Medicare.
引用
收藏
页码:2653 / 2658
页数:6
相关论文
共 35 条
[1]  
ADAMS PF, 1995, NATL CTR HLTH STAT V, V10, P1
[2]  
*AM THOR SOC, 1995, AM J RESP CRIT CARE, V152, pS78, DOI [10.1164/ajrccm/152.5_Pt_2.S78, DOI 10.1164/AJRCCM/152.5_PT_2.S78]
[3]  
*AMA, 1996, PHYS CURR PROC TERM
[4]   Fixing Medicare [J].
Angell, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :192-195
[5]  
[Anonymous], 1999, International classification of diseases, clinical modification: Ninth revision, tenth edition
[6]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[7]   Geographic variations in utilization rates in Veterans Affairs hospitals and clinics [J].
Ashton, CM ;
Petersen, MPHNJ ;
Souchek, J ;
Menke, TJ ;
Yu, HJ ;
Pietz, K ;
Eigenbrodt, ML ;
Barbour, G ;
Kizer, KW ;
Wray, NP .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (01) :32-39
[8]  
Cannon C, 1998, AM J RESP CRIT CARE, V158, P320
[9]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[10]   Outcomes following acute exacerbation of severe chronic obstructive lung disease [J].
Connors, AF ;
Dawson, NV ;
Thomas, C ;
Harrell, FE ;
Desbiens, N ;
Fulkerson, WJ ;
Kussin, P ;
Bellamy, P ;
Goldman, L ;
Knaus, WA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :959-967